chronic fatigue therapy

Generic: epinephrine, gold, chelidonium majus, echinacea, ginkgo, helleborus niger, phosphoric acid, scutellaria lateriflora, thuja occidentalis

Labeler: trp company
NDC Directory HUMAN OTC DRUG UNAPPROVED HOMEOPATHIC Inactive Finished

Drug Facts

Product Profile

Brand Name chronic fatigue therapy
Generic Name epinephrine, gold, chelidonium majus, echinacea, ginkgo, helleborus niger, phosphoric acid, scutellaria lateriflora, thuja occidentalis
Labeler trp company
Dosage Form TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Active Ingredients

chelidonium majus 6 [hp_X]/1, echinacea, unspecified 3 [hp_X]/1, epinephrine 7 [hp_X]/1, ginkgo 3 [hp_X]/1, gold 8 [hp_X]/1, helleborus niger root 6 [hp_X]/1, phosphoric acid 6 [hp_X]/1, scutellaria lateriflora 6 [hp_X]/1, thuja occidentalis leafy twig 6 [hp_X]/1

Manufacturer
TRP Company

Identifiers & Regulatory

Product NDC 17312-170
Product ID 17312-170_4604f3de-7763-ddaa-e063-6394a90a78d0
Product Type HUMAN OTC DRUG
Marketing Category UNAPPROVED HOMEOPATHIC
Listing Expiration 2026-12-31
Marketing Start 2018-08-20

Pharmacologic Class

Established (EPC)
alpha-adrenergic agonist [epc] beta-adrenergic agonist [epc] catecholamine [epc] standardized chemical allergen [epc]
Mechanism of Action
adrenergic alpha-agonists [moa] adrenergic beta-agonists [moa]
Chemical Structure
catecholamines [cs] allergens [cs]
Physiologic Effect
increased histamine release [pe] cell-mediated immunity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 17312170
Hyphenated Format 17312-170

Supplemental Identifiers

UPC
0858961001709
UNII
7E889U5RNN 4N9P6CC1DX YKH834O4BH 19FUJ2C58T 79Y1949PYO 608DGJ6815 E4GA8884NN 7BP4DH5PDC 1NT28V9397
NUI
N0000000209 N0000000245 N0000175552 N0000175555 N0000175570 M0003647 N0000185508 N0000175629 N0000184306 M0000728

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name chronic fatigue therapy (source: ndc)
Generic Name epinephrine, gold, chelidonium majus, echinacea, ginkgo, helleborus niger, phosphoric acid, scutellaria lateriflora, thuja occidentalis (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 6 [hp_X]/1
  • 3 [hp_X]/1
  • 7 [hp_X]/1
  • 8 [hp_X]/1
source: ndc
Packaging
  • 1 BOTTLE in 1 PACKAGE (17312-170-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
source: ndc

Packages (1)

17312-170-14 1 BOTTLE in 1 PACKAGE (17312-170-14) / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE

Ingredients (9)

chelidonium majus (6 [hp_X]/1) echinacea, unspecified (3 [hp_X]/1) epinephrine (7 [hp_X]/1) ginkgo (3 [hp_X]/1) gold (8 [hp_X]/1) helleborus niger root (6 [hp_X]/1) phosphoric acid (6 [hp_X]/1) scutellaria lateriflora (6 [hp_X]/1) thuja occidentalis leafy twig (6 [hp_X]/1)

Linked Drug Pages (1)

Chronic Fatigue Therapy ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4604f3de-7763-ddaa-e063-6394a90a78d0", "openfda": {"nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647", "N0000185508", "N0000175629", "N0000184306", "M0000728"], "upc": ["0858961001709"], "unii": ["7E889U5RNN", "4N9P6CC1DX", "YKH834O4BH", "19FUJ2C58T", "79Y1949PYO", "608DGJ6815", "E4GA8884NN", "7BP4DH5PDC", "1NT28V9397"], "spl_set_id": ["751334b8-f21b-3f94-e053-2a91aa0a9bb9"], "pharm_class_cs": ["Catecholamines [CS]", "Allergens [CS]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]", "Standardized Chemical Allergen [EPC]"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "manufacturer_name": ["TRP Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 PACKAGE (17312-170-14)  / 70 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE", "package_ndc": "17312-170-14", "marketing_start_date": "20180820"}], "brand_name": "Chronic Fatigue Therapy", "product_id": "17312-170_4604f3de-7763-ddaa-e063-6394a90a78d0", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Allergens [CS]", "Catecholamine [EPC]", "Catecholamines [CS]", "Cell-mediated Immunity [PE]", "Increased Histamine Release [PE]", "Standardized Chemical Allergen [EPC]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "17312-170", "generic_name": "EPINEPHRINE, GOLD, CHELIDONIUM MAJUS, ECHINACEA, GINKGO, HELLEBORUS NIGER, PHOSPHORIC ACID, SCUTELLARIA LATERIFLORA, THUJA OCCIDENTALIS", "labeler_name": "TRP Company", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Chronic Fatigue Therapy", "active_ingredients": [{"name": "CHELIDONIUM MAJUS", "strength": "6 [hp_X]/1"}, {"name": "ECHINACEA, UNSPECIFIED", "strength": "3 [hp_X]/1"}, {"name": "EPINEPHRINE", "strength": "7 [hp_X]/1"}, {"name": "GINKGO", "strength": "3 [hp_X]/1"}, {"name": "GOLD", "strength": "8 [hp_X]/1"}, {"name": "HELLEBORUS NIGER ROOT", "strength": "6 [hp_X]/1"}, {"name": "PHOSPHORIC ACID", "strength": "6 [hp_X]/1"}, {"name": "SCUTELLARIA LATERIFLORA", "strength": "6 [hp_X]/1"}, {"name": "THUJA OCCIDENTALIS LEAFY TWIG", "strength": "6 [hp_X]/1"}], "marketing_category": "UNAPPROVED HOMEOPATHIC", "marketing_start_date": "20180820", "listing_expiration_date": "20261231"}